DIVIS LABORATORIES
|
The Current P/E Ratio of DIVIS LABORATORIES is 64.40.
| Share Price | ₹6,013.0 | Mar 25,2026 |
| Market Cap | ₹159,643.8 Cr | |
| Earnings-TTM | ₹2,479.0 Cr | TTM-Consolidated Results |
| Price/Earnings | 64.40x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of DIVIS LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹159,643.8 Cr] as on Mar 25,2026
(/) Earnings [ ₹2,479.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 64.40x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay 64.40 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of DIVIS LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of DIVIS LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of DIVIS LABORATORIES
PE Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 51.17x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 48.56x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2025 at 69.83x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2022 of 39.49x.
How does DIVIS LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| DIVIS LABORATORIES | 2,479.00 | 64.40 | 159,643.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 39.14 | 430,645.0 |
| CIPLA LTD | 4,544.70 | 22.11 | 100,480.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 64.00 | 145,415.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.73 | 108,664.0 |
| MANKIND PHARMA LTD | 1,796.65 | 46.42 | 83,401.6 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.43 | 90,923.3 |
| LUPIN LTD | 4,669.18 | 22.98 | 107,321.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 21.62 | 75,951.4 |
| ABBOTT INDIA LTD | 1,524.13 | 36.80 | 56,092.5 |
| ALKEM LABORATORIES LTD | 2,424.46 | 26.80 | 64,983.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs DIVIS LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.43x |
| Max industry PE | 64.40x |
| Median industry PE | 26.80x |
| Average industry PE | 34.77x |
You may also like the below Video Courses